Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles

Detalhes bibliográficos
Autor(a) principal: Borges, Olga
Data de Publicação: 2008
Outros Autores: Cordeiro-da-Silva, Anabela, Tavares, Joana, Santarém, Nuno, Sousa, Adriano de, Borchard, Gerrit, Junginger, Hans E.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/5833
https://doi.org/10.1016/j.ejpb.2008.01.019
Resumo: Alginate coated chitosan nanoparticles were previously developed with the aim of protecting the antigen, adsorbed on the surface of those chitosan nanoparticles, from enzymatic degradation at mucosal surfaces. In this work, this new delivery system was loaded with the recombinant hepatitis B surface antigen (HBsAg) and applied to mice by the intranasal route. Adjuvant effect of the delivery system was studied by measuring anti-HBsAg IgG in serum, anti-HBsAg sIgA in faeces extracts or nasal and vaginal secretions and interferon-[gamma] production in supernatants of the spleen cells. The mice were primed with 10 [mu]g of the vaccine associated or not with nanoparticles and associated or not with 10 [mu]g CpG oligodeoxynucleotide (ODN) followed by two sequential boosts at three week intervals. The association of HBsAg with the alginate coated chitosan nanoparticles, administered intranasally to the mice, gave rise to the humoral mucosal immune response. Humoral systemic immune response was not induced by the HBsAg loaded nanoparticles alone. The generation of Th1-biased antigen-specific systemic antibodies, however, was observed when HBsAg loaded nanoparticles were applied together with a second adjuvant, the immunopotentiator, CpG ODN. Moreover, all intranasally vaccinated groups showed higher interferon-[gamma] production when compared to naïve mice.
id RCAP_a897ee7570fa2b67b83b08739c41f4c2
oai_identifier_str oai:estudogeral.uc.pt:10316/5833
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticlesIntranasal vaccinationHepatitis B surface antigenCpG oligodeoxynucleotideAlginate coated chitosan nanoparticlesVaccinesAlginate coated chitosan nanoparticles were previously developed with the aim of protecting the antigen, adsorbed on the surface of those chitosan nanoparticles, from enzymatic degradation at mucosal surfaces. In this work, this new delivery system was loaded with the recombinant hepatitis B surface antigen (HBsAg) and applied to mice by the intranasal route. Adjuvant effect of the delivery system was studied by measuring anti-HBsAg IgG in serum, anti-HBsAg sIgA in faeces extracts or nasal and vaginal secretions and interferon-[gamma] production in supernatants of the spleen cells. The mice were primed with 10 [mu]g of the vaccine associated or not with nanoparticles and associated or not with 10 [mu]g CpG oligodeoxynucleotide (ODN) followed by two sequential boosts at three week intervals. The association of HBsAg with the alginate coated chitosan nanoparticles, administered intranasally to the mice, gave rise to the humoral mucosal immune response. Humoral systemic immune response was not induced by the HBsAg loaded nanoparticles alone. The generation of Th1-biased antigen-specific systemic antibodies, however, was observed when HBsAg loaded nanoparticles were applied together with a second adjuvant, the immunopotentiator, CpG ODN. Moreover, all intranasally vaccinated groups showed higher interferon-[gamma] production when compared to naïve mice.http://www.sciencedirect.com/science/article/B6T6C-4RR1NPN-2/1/beaa4e06ecb340a5a293ef1fd3b4c8662008info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleaplication/PDFhttp://hdl.handle.net/10316/5833http://hdl.handle.net/10316/5833https://doi.org/10.1016/j.ejpb.2008.01.019engEuropean Journal of Pharmaceutics and Biopharmaceutics. 69:2 (2008) 405-416Borges, OlgaCordeiro-da-Silva, AnabelaTavares, JoanaSantarém, NunoSousa, Adriano deBorchard, GerritJunginger, Hans E.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-05-25T03:11:40Zoai:estudogeral.uc.pt:10316/5833Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:47:24.950257Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
title Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
spellingShingle Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
Borges, Olga
Intranasal vaccination
Hepatitis B surface antigen
CpG oligodeoxynucleotide
Alginate coated chitosan nanoparticles
Vaccines
title_short Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
title_full Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
title_fullStr Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
title_full_unstemmed Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
title_sort Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
author Borges, Olga
author_facet Borges, Olga
Cordeiro-da-Silva, Anabela
Tavares, Joana
Santarém, Nuno
Sousa, Adriano de
Borchard, Gerrit
Junginger, Hans E.
author_role author
author2 Cordeiro-da-Silva, Anabela
Tavares, Joana
Santarém, Nuno
Sousa, Adriano de
Borchard, Gerrit
Junginger, Hans E.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Borges, Olga
Cordeiro-da-Silva, Anabela
Tavares, Joana
Santarém, Nuno
Sousa, Adriano de
Borchard, Gerrit
Junginger, Hans E.
dc.subject.por.fl_str_mv Intranasal vaccination
Hepatitis B surface antigen
CpG oligodeoxynucleotide
Alginate coated chitosan nanoparticles
Vaccines
topic Intranasal vaccination
Hepatitis B surface antigen
CpG oligodeoxynucleotide
Alginate coated chitosan nanoparticles
Vaccines
description Alginate coated chitosan nanoparticles were previously developed with the aim of protecting the antigen, adsorbed on the surface of those chitosan nanoparticles, from enzymatic degradation at mucosal surfaces. In this work, this new delivery system was loaded with the recombinant hepatitis B surface antigen (HBsAg) and applied to mice by the intranasal route. Adjuvant effect of the delivery system was studied by measuring anti-HBsAg IgG in serum, anti-HBsAg sIgA in faeces extracts or nasal and vaginal secretions and interferon-[gamma] production in supernatants of the spleen cells. The mice were primed with 10 [mu]g of the vaccine associated or not with nanoparticles and associated or not with 10 [mu]g CpG oligodeoxynucleotide (ODN) followed by two sequential boosts at three week intervals. The association of HBsAg with the alginate coated chitosan nanoparticles, administered intranasally to the mice, gave rise to the humoral mucosal immune response. Humoral systemic immune response was not induced by the HBsAg loaded nanoparticles alone. The generation of Th1-biased antigen-specific systemic antibodies, however, was observed when HBsAg loaded nanoparticles were applied together with a second adjuvant, the immunopotentiator, CpG ODN. Moreover, all intranasally vaccinated groups showed higher interferon-[gamma] production when compared to naïve mice.
publishDate 2008
dc.date.none.fl_str_mv 2008
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/5833
http://hdl.handle.net/10316/5833
https://doi.org/10.1016/j.ejpb.2008.01.019
url http://hdl.handle.net/10316/5833
https://doi.org/10.1016/j.ejpb.2008.01.019
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv European Journal of Pharmaceutics and Biopharmaceutics. 69:2 (2008) 405-416
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv aplication/PDF
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133751184195584